Raul Perez-Olle

Raul Perez-Olle has a long history of experience in the medical field. Currently, they are the SVP, Head of Medical Affairs and Late-Stage Clinical Development at Imvax, Inc., a position they have held since 2022. Prior to this, they were the Entrepreneur-in-Residence at Stevens Venture Center from 2019 to 2021. From 2016 to 2019, they held two positions at MacroGenics, Inc., as Vice President, Global Medical Affairs and Clinical Development and Vice President, Medical Affairs. Raul was also the Executive Director, Head of Medical Affairs at Lexicon Pharmaceuticals, Inc. from 2016 to 2019. From 2016 to 2021, they were the Medical Director, Immuno-Oncology, Global Research and Early Development at EMD Serono, Inc. Raul was the Head, US Oncology Medical Affairs at Sandoz from 2015 to 2016 and the Executive Director, Clinical Development and Medical Affairs, Oncology at Boehringer Ingelheim from 2013 to 2015. Lastly, they were the Senior Director, Medical Affairs, Oncology at Otsuka America Pharmaceutical, Inc. from 2011 to 2013.

Raul Perez-Olle obtained their Doctor of Medicine - MD from the Universitat Rovira i Virgili and their Doctor of Philosophy (PhD) from Columbia University.